PISCITELLI, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 1.711
EU - Europa 457
AS - Asia 193
AF - Africa 53
SA - Sud America 19
OC - Oceania 1
Totale 2.434
Nazione #
US - Stati Uniti d'America 1.704
IT - Italia 188
IN - India 104
SE - Svezia 87
UA - Ucraina 70
CN - Cina 66
FI - Finlandia 63
TG - Togo 51
SG - Singapore 21
AR - Argentina 19
DE - Germania 11
GB - Regno Unito 9
IE - Irlanda 8
CA - Canada 6
BG - Bulgaria 4
RO - Romania 4
NL - Olanda 3
BE - Belgio 2
DK - Danimarca 2
ES - Italia 2
FR - Francia 2
CH - Svizzera 1
GR - Grecia 1
HK - Hong Kong 1
IR - Iran 1
MX - Messico 1
NZ - Nuova Zelanda 1
SC - Seychelles 1
ZA - Sudafrica 1
Totale 2.434
Città #
Fairfield 259
Chandler 211
Ashburn 126
Woodbridge 123
Fasano 103
Seattle 98
Houston 93
Wilmington 83
Cambridge 76
Ann Arbor 70
Princeton 53
Plano 52
Dearborn 51
Lomé 51
Rome 39
Fremont 32
Jacksonville 26
San Diego 26
Beijing 25
San Paolo di Civitate 22
Boston 19
Federal 19
Millbury 19
Des Moines 17
Lawrence 16
Andover 13
Helsinki 12
Falls Church 11
New York 8
Dublin 7
Cagliari 6
Singapore 6
Toronto 6
Boardman 5
Hefei 5
Norwalk 5
Fuzhou 4
Indore 4
Jinan 4
Kunming 4
Sofia 4
Washington 4
Bremen 3
Indiana 3
Brussels 2
Florence 2
Galdo 2
Grafing 2
Grottammare 2
Laurel 2
London 2
Nanchang 2
Nanjing 2
Paris 2
Redmond 2
San Francisco 2
Bangalore 1
Baotou 1
Barcelona 1
Bern 1
Buffalo 1
Bühl 1
Caserta 1
Chaoyang 1
Chengdu 1
Chongqing 1
Civitavecchia 1
Edinburgh 1
Guangzhou 1
Hangzhou 1
Henderson 1
Lanzhou 1
Mexico City 1
Milan 1
Muizenberg 1
Nanning 1
Ningbo 1
Palermo 1
Provo 1
Quzhou 1
Redwood City 1
Rende 1
Reston 1
San Mateo 1
Scotshouse 1
Shanghai 1
Shenyang 1
Southend 1
Trumbull 1
Wanchai 1
Wellington 1
Wuhan 1
Xian 1
Zhengzhou 1
Zhongxin 1
Totale 1.886
Nome #
1-[(3-Aryloxy-3-aryl)propyl]-2H-imidazoles, new imidazoles with potent activity against Candida albicans and dermatophytes. Synthesis, structure-activity relationship, and molecular modeling studies 93
New arylthioindoles and related bioisosteres at the sulfur bridging group. 4. Synthesis, tubulin polymerization, cell growth inhibition, and molecular modeling studies 90
Arylthioindole Inhibitors of Tubulin Polymerization. 3. Biological Evaluation, Structure−Activity Relationships and Molecular Modeling Studies 87
Synthesis, Cannabinoid Receptor Affinity and Molecular Modeling Studies of Substituted 1-Aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides. 84
Mechanism of interaction of novel indolylarylsulfone derivatives with K103N and Y181I mutant HIV-1 reverse transcriptase in complex with its substrates 81
1-Aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide: an effective scaffold for the design of either CB1 or CB2 receptor ligands. 77
Indole-2-carboxamides as Allosteric Modulators of the Cannabinoid CB1 Receptor 72
Design, molecular modeling, synthesis, and anti-HIV-1 activity of new indolyl aryl sulfones. Novel derivatives of the indole-2-carboxamide 71
Toward Highly Potent Cancer Agents by Modulating the C-2 Group of the Arylthioindole Class of Tubulin Polymerization Inhibitors 70
Open vessel and cooling while heating microwave-assisted synthesis of pyridinyl N-aryl hydrazones 69
Non-nucleoside HIV-1 reverse transcriptase inhibitors di-halo-indolyl aryl sulfones achieve tight binding to drug-resistant mutants by targeting the enzyme-substrate complex. 67
An improved synthesis of ethyl 5-chloro-4-fluoro-1H-indole-2-carboxylate 66
Indolylarylsulfones as HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: New Cyclic Substituents at the Indole-2-carboxamide. 66
Arylthioindoles, Potent Inhibitors of Tubulin Polymerization. 65
Design and Synthesis of 2-Heterocyclyl-3-arylthio-1H-indoles as Potent Tubulin Polymerization and Cell Growth Inhibitors with Improved Metabolic Stability 65
Indole nucleus as a selected pharmacophore for the design of novel highly anti-HIV RT inhibitors and also capable to inhibit tumor cell replication. 64
Indolylarylsulfones as HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors. New Cyclic Substituents at the Indole-2-carboxamide. 64
1-Aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide: an effective scaffold for the design of either CB1 or CB2 receptor ligands. 63
Synthesis, cannabinoid receptor affinity, molecular modeling studies and in vivo pharmacological evaluation of new substituted 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides. 2. Effect of the 3-carboxamide substituent on the affinity and selectivity profile 62
Arylthioindoles: Promising compounds against cancer cell proliferation. 58
New Nitrogen Containing Substituents at the Indole-2-carboxamide Yield High Potent and Broad Spectrum Indolylarylsulfone HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors 57
Indolyl Aryl Sulfones as HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: Role of Two Halogen Atoms at the Indole Ring in Developing New Analogues with Improved Antiviral Activity 56
Synthesis and biological evaluation of new N-alkyl 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides as cannabinoid receptor ligands. 55
Study of the effects of a new pyrazolecarboxamide: Changes in mitochondria and induction of apoptosis 53
Venting-while-heating microwave-assisted synthesis of 3-arylthioindoles 48
Arylthioindoles: Docking and Molecular Dynamics Studies. 41
A new allosteric inhibitor of the hepatitis C virus NS5B polymerase is effective on HCV replication in infected cell culture system. 39
Enantioselective HPLC combined with spectroscopic methods: A valid strategy to determine the absolute configuration of potential beta-secretase inhibitors 37
Docking and Molecular Dynamics Studies of Arylthioindoles. 36
Design, synthesis and anti-HIV activity of new indolyl aryl sulfones (IASs): structure-activity relationship of substituents on the 2-carboxyamides function 36
Indolylarylsulfones Bearing Natural and Unnatural Amino Acids as Potent HIV-1 NNRTIs. 36
Docking and Molecular Dynamics Studies of Arylthioindoles. 33
Arylthioindoles: Design, Synthesis and Biological Activity 32
Computer aided drug design approach in the development of PKnB inhibitors as potential antimycobacterial agents. 32
Substituted 1-Aryl-5-(1H-pyrrol-1-yl)-1H-Pyrazole-3-Carboxamides as Potent Pyrrole Bioisosteres of Rimonabant and SR144528. 32
Synthesis, in vivo pharmacological evaluation and pharmacokinetic studies of N-alkyl 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide cannabinoid receptor ligands. 31
Effects of a new arylthioindole on HeLa cell metabolism 27
Indolyl Aryl Sulfones bearing Natural and Unnatural Aminoacids. Discovery of Potent Inhibitors of both HIV-1 Non-Nucleoside Wild Type and Resistant Mutant Strains Reverse Transcriptase, and Coxsackie B4 Virus. 27
Indolylarylsulfones bearing natural and unnatural amino acids as inhibitors of HIV-1 reverse transcriptase and Coxsackie B4 virus. 26
Indolylarylsulfones Bearing Natural and Unnatural Amino Acids are Potent HIV-1 Reverse Transcriptase and Coxsackie B4 Virus Non-Nucleoside Inhibitors. 26
Indolilarilsolfoni, potenti e selettivi agenti anti-HIV 25
Induction of Apoptosis in Human Tumor Cells by a New Pyrazolcarboxamide 24
New N-Alkyl 1-Aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides as potent cannabinoid receptor ligands. 24
Pirazolocarbossiamidi e morte cellulare: una nuova arma per la chemioterapia. 24
Progress in the development of arylthioindoles, potent inhibitors of tubulin polymerization and MCF-7 cell growth. 24
Indolyl Aryl Sulfones with aminoacid units as potent HIV-1 NNRTIs. 23
Synthesis of Indol Aryl Sulfones bearing Natural and Unnatural Aminoacids as Potent HIV-1 Non-Nucleoside Reverse Transcriptase. 22
Substituted 1-Aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides, as Potent Pyrrole Bioisosteres of Rimonabant and SR144528. 20
New Substituted 1-Aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides as High Affinity hCB1 Ligands 18
New Indolyl Aryl Sulfones (IASs) as potent anti-HIV agents. 17
Progress in the development of arylthioindoles, potent inhibitors of tubulin polymerization and MCF-7 cell growth. 16
Synthetic Strategies of Non-Peptidic beta-Secretase (BACE1) Inhibitors. 15
Totale 2.446
Categoria #
all - tutte 6.045
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.045


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019237 0 0 0 0 0 0 0 0 0 49 107 81
2019/2020573 84 12 4 23 50 131 81 70 59 32 19 8
2020/2021285 13 19 9 29 2 37 8 18 11 20 17 102
2021/2022426 4 33 42 8 61 10 9 41 42 39 40 97
2022/2023582 95 150 20 72 69 61 6 28 43 16 21 1
2023/2024164 16 31 10 10 20 26 3 26 0 22 0 0
Totale 2.446